by Legal Desire

Lawyer profile

Rachelle Polsky

Latham & Watkins LLP

Claim this profile

Firm: Latham & Watkins LLP
Practice: corporate, M&A
Office: Not stated
Active in the record: 2020 to 2026

Deal experience

Deal types

M&A Venture Capital & Growth

Sectors

Healthcare & Life Sciences Technology

Jurisdictions

Europe United States

Deals

5 announced deals in the record

Latham Advises Dragoneer on Helsing’s US$1.8 Billion Series E, Valuing the Company at US$18 Billion in One of the Largest Defense Tech Investments Globally 15 Jul 2026

Venture Capital & Growth Technology Latham & Watkins LLP USD 1.80bn

Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals 5 Dec 2024

M&A Healthcare & Life Sciences Latham & Watkins LLP USD 558m corporate

Latham & Watkins Advises Goldman Sachs in Acquisition of Xpress Wellness 24 May 2024

M&A Healthcare & Life Sciences Latham & Watkins LLP corporate

Latham & Watkins Represents Purigen Biosystems in Its Acquisition by Bionano Genomics 2 Dec 2022

M&A Healthcare & Life Sciences Latham & Watkins LLP corporate

Latham & Watkins Advises Apex Technology Acquisition Corporation in Business Combination with AvePoint 23 Nov 2020

M&A Technology Latham & Watkins LLP USD 2bn M&A

Deal alerts PRO

Get an email when Rachelle Polsky is named on a newly announced deal.

Alerts come as one daily email at most.

Pro

Analytics for Rachelle Polsky

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

Complete deal history, filtered by keyword, deal type, sector and year
Deals by year, sector and deal type
Frequent co-counsel and the firms most often on the other side
Repeat clients, as named in the announcements
CSV and Excel export

SEE PLANS SIGN IN

Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction